An antibacterial composition and its preparation method and application
By developing an antibacterial composition containing green tea extract, pomegranate peel extract and grape seed extract, the problem that existing products cannot effectively inhibit pseudo-intermediate Staphylococcus is solved, and significant antibacterial effect and safety are achieved. Reduces recurrence rates and medication side effects of pet skin diseases.
Patent Information
- Application Number
- CN202411273762.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-09-12
AI Technical Summary
Existing pet skin care products cannot effectively inhibit pseudo-intermediate Staphylococcus, resulting in a high recurrence rate of pet skin diseases, and the use of antibiotics on the market has side effects and environmental hazards.
Develop an antibacterial composition, including green tea extract, pomegranate peel extract and grape seed extract, combined with auxiliary materials such as cinnamon extract, peppermint oil, gel polymer excipients, etc., to significantly reduce pseudo-intermediate grapes through synergistic effects The growth, adhesion and bactericidal ability of cocci.
This antibacterial composition significantly inhibits the growth and adhesion of pseudo-intermediate Staphylococcus, safely and effectively alleviates the symptoms of redness, itching, herpes and abscess in pet skin, reduces the recurrence rate, and avoids the risk of infection of pet owners.
Smart Images

Figure CN118787700B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of dermatological drugs, and in particular relates to an antibacterial composition and a preparation method and application thereof. Background Art
[0002] Skin diseases are common in dogs and cats. According to the 2023-2024 China Pet Medical White Paper, the rate of visits for pet skin diseases ranks first among clinical cases, accounting for about 15%-20%. Skin diseases in dogs and cats can cause a series of symptoms, such as epidermal redness, itching, herpes caused by primary infection, and abscesses caused by secondary infection. It has a long pathological cycle and is a disease that is common to both humans and pets, with a long course of illness and a recurrence rate of up to 77%. At the same time, skin diseases can easily lead to abnormal behaviors such as scratching in pets, resulting in impaired animal welfare. It is reported that among zoonotic pathogens, 30-40 pathogens come from dogs and cats, which can easily cause pathogens to spread between pets and humans and cause public health problems.
[0003] Bacterial skin diseases are pathological changes in the skin caused by bacterial pathogens, and are the most important type of skin diseases. Staphylococcus pseudointermedius is the main pathogen in bacterial skin diseases in pets, and more than 52% of bacterial skin diseases are caused by Staphylococcus pseudointermedius. Skin diseases caused by Staphylococcus pseudointermedius not only lead to purulent infections and local lesions on the skin of sick pets, but may also induce systemic infections in severe cases. Therefore, inhibition of Staphylococcus pseudointermedius is an important target for the treatment of pet skin diseases.
[0004] At present, the pet skin care products on the market mainly target bacteria such as Staphylococcus aureus, Escherichia coli, Corynebacterium pyogenes, Pseudomonas aeruginosa, etc., rather than the main pathogens of pet skin diseases. For example, the Chinese invention patent with publication number CN117715651A discloses a composition for treating local skin bacterial skin diseases, which contains a therapeutically effective amount of Croton lechleri tree extract, which can be used to treat skin diseases caused by Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), mupirocin-resistant MRSA, etc., but cannot treat skin diseases caused by Staphylococcus pseudointermedius.
[0005] At the same time, the means used in the market to treat bacterial skin diseases in pets are basically the continuous long-term use of antibiotics or antiparasitic drugs such as ketoconazole, florfenicol and terbinafine hydrochloride. For example, the Chinese invention patent with publication number CN112245438A discloses an antibacterial composition and its compound marbofloxacin spray and preparation method. The compound marbofloxacin spray includes: an antibacterial composition, ketoconazole, prednisolone, etc., and these drugs have many side effects, harm to the environment, and pathogen resistance.
[0006] Natural products extracted from plants are low-toxic and safe, and many of them have certain antibacterial activity and have the potential to be used as alternative antibiotics to treat skin diseases in dogs and cats. As a medicinal dressing, hydrogel provides a moisturizing, breathable and gentle treatment environment for pet wounds with its unique texture and properties. It can fit the affected area, form a protective layer, and prevent external contamination, which is essential for cell growth and tissue repair. At the same time, the gel mesh structure of the hydrogel helps to effectively release and maintain the release of active ingredients in the wound, enhancing the therapeutic effect. Therefore, developing a new, effective and safe natural antibacterial composition for pet owners is the key to fundamentally solving pet skin diseases and providing a reference for the clinical treatment and prevention of pet bacterial skin diseases. Summary of the invention
[0007] In view of this, the present invention aims to provide an antibacterial composition and a preparation method and application thereof, which can inhibit Staphylococcus pseudintermedius and relieve the symptoms of redness, itching, herpes and abscesses on the pet's skin.
[0008] To achieve the above object, the technical solution of the present invention is achieved as follows:
[0009] In a first aspect, the present invention provides an antibacterial composition, comprising: green tea extract, pomegranate peel extract, and grape seed extract.
[0010] Furthermore, the bacteria is Staphylococcus pseudintermedius, and the antibacterial composition is a composition against Staphylococcus pseudintermedius.
[0011] Furthermore, the antibacterial composition comprises, by weight: 0.5-2 parts of green tea extract, 0.5-2 parts of pomegranate peel extract, and 0.5-2 parts of grape seed extract.
[0012] Furthermore, the antibacterial composition also includes auxiliary materials.
[0013] Furthermore, the auxiliary materials include at least one of cinnamon extract, peppermint oil, rhamnose, mannose, gel polymer excipient, moisturizer, aloe polysaccharide, zinc hyaluronate, zinc gluconate, zinc citrate, PEG-40 castor oil, and triethanolamine.
[0014] Furthermore, the antibacterial composition further comprises, by mass, 0.01-0.1 parts of cinnamon extract, 0.1-1 parts of peppermint oil, 0.5-1.5 parts of rhamnose, 0.5-1 parts of mannose, 0.5-1 parts of gel polymer excipient, 5-20 parts of moisturizer, 0.1-2 parts of aloe polysaccharide, 0.2-1 parts of zinc hyaluronate, 0.1-1 parts of zinc gluconate, 0.1-0.5 parts of zinc citrate, 0.5-3 parts of PEG-40 castor oil, and 0.5-2 parts of triethanolamine.
[0015] The antibacterial composition of the present invention uses plant extracts with natural antibacterial properties, which can directly inhibit Staphylococcus pseudointermedia, block the adhesion and colonization of harmful bacteria on the skin, and safely and effectively inhibit their reproduction on the skin;
[0016] The antibacterial composition of the present invention is completely based on natural ingredients, avoiding the health risks that may be caused by chemical ingredients. The addition of herbal antibacterial ingredients also ensures the mildness of the product, non-irritation, and no drug resistance. It can be used by both pregnant pets and young pets, and can ensure the long-term health of pets with high safety.
[0017] The natural antibacterial plant extract added to the antibacterial composition of the present invention is specially designed for Staphylococcus pseudointermedius, the main pathogenic bacteria of bacterial skin diseases of pets, thereby improving the efficiency and effect of solving bacterial skin diseases of pets and having strong pertinence.
[0018] Furthermore, the antibacterial composition includes, by mass, 0.5-1 part of green tea extract, 0.5-1 part of pomegranate peel extract, 0.5-1 part of grape seed extract, 0.01-0.1 part of cinnamon extract, 0.1-1 part of peppermint oil, 0.5-1 part of rhamnose, 0.5 part of mannose, 0.5-1 part of gel polymer excipient, 5-14 parts of moisturizer, 0.1-2 parts of aloe polysaccharide, 0.2-1 part of zinc hyaluronate, 0.1-1 part of zinc gluconate, 0.1-0.5 part of zinc citrate, 0.5-3 parts of PEG-40 castor oil, and 0.5-2 parts of triethanolamine.
[0019] Preferably, the antibacterial composition comprises, by mass: 1 part of green tea extract, 0.5 part of pomegranate peel extract, 0.5 part of grape seed extract, 0.01-0.1 part of cinnamon extract, 0.1-1 part of peppermint oil, 0.5-1 part of rhamnose, 0.5-1 part of mannose, 0.51-1 part of gel polymer excipient, 5-10 parts of moisturizer, 1-2 parts of aloe polysaccharide, 0.5-1 part of zinc hyaluronate, 0.3-1 part of zinc gluconate, 0.2-0.5 part of zinc citrate, 2-3 parts of PEG-40 castor oil, and 1-2 parts of triethanolamine.
[0020] Preferably, the antibacterial composition comprises, by mass: 1 part of green tea extract, 0.5 part of pomegranate peel extract, 0.5 part of grape seed extract, 0.01 part of cinnamon extract, 0.1 part of peppermint oil, 1 part of rhamnose, 0.5 part of mannose, 1 part of gel polymer excipient, 10 parts of moisturizer, 1 part of aloe polysaccharide, 0.5 part of zinc hyaluronate, 0.3 part of zinc gluconate, 0.2 part of zinc citrate, 2 parts of PEG-40 castor oil, and 1 part of triethanolamine.
[0021] Furthermore, the molecular weight of the zinc hyaluronate is 100-500 kDa.
[0022] Furthermore, the gel polymer excipient includes at least one of carbomer 934 and hydroxypropyl methylcellulose; preferably, the gel polymer excipient is carbomer 934 and hydroxypropyl methylcellulose.
[0023] Furthermore, the moisturizing agent includes at least one of glycerin and sorbitol; preferably, the moisturizing agent is glycerin and sorbitol.
[0024] In a second aspect, the present invention provides a method for preparing the antibacterial composition as described above, the preparation method comprising the following steps:
[0025] Green tea extract, pomegranate peel extract, grape seed extract and water are stirred until completely dissolved to obtain a plant extract antibacterial liquid.
[0026] Furthermore, the preparation method comprises the following steps:
[0027] Green tea extract, pomegranate peel extract, grape seed extract, and cinnamon extract are stirred with water until completely dissolved to obtain a plant extract antibacterial liquid;
[0028] Aloe polysaccharide, rhamnose, mannose and water are mixed, and then subjected to shear emulsification and high-pressure homogenization to obtain a polysaccharide antibacterial liquid;
[0029] Stirring zinc hyaluronate and water until completely dissolved to obtain zinc hyaluronate solution;
[0030] The gel polymer excipient and water are mixed evenly, and allowed to stand at room temperature to fully hydrate and swell, to obtain a first component;
[0031] Stir zinc gluconate, zinc citrate, castor oil, peppermint oil and water until completely dissolved to obtain a second component;
[0032] The first component, moisturizer and triethanolamine are evenly ground, mixed with the second component, and stirred until the hydrogel matrix is formed. Plant extract antibacterial liquid, polysaccharide antibacterial liquid and hyaluronic acid zinc liquid are added in sequence, stirred evenly and the pH is adjusted to obtain an antibacterial composition.
[0033] Furthermore, when preparing the plant extract antibacterial liquid, the stirring temperature is 40-60°C, the stirring rate is 5000-8000rpm, the stirring time is 5-20min, and after stirring until completely dissolved, it is cooled to room temperature to obtain the plant extract antibacterial liquid; preferably, the stirring temperature is 40-50°C, the stirring rate is 6000-7000rpm, and the stirring time is 8-15min; further preferably, the stirring temperature is 45°C, the stirring rate is 6500rpm, and the stirring time is 10min.
[0034] Furthermore, when preparing the polysaccharide antibacterial liquid, the speed of shear emulsification is 8000-15000rpm, and the pressure of high-pressure homogenization is 50-80MPa; preferably, the speed of shear emulsification is 9000-12000rpm, and the pressure of high-pressure homogenization is 55-70MPa; further preferably, the speed of shear emulsification is 10000rpm, and the pressure of high-pressure homogenization is 60MPa.
[0035] Furthermore, when preparing the hyaluronate zinc solution, the stirring temperature is 40-60°C, the stirring speed is 500-2000rpm, and the stirring time is 0.5-2h; preferably, the stirring temperature is 45-55°C, the stirring speed is 500-1500rpm, and the stirring time is 0.5-1.5h; further preferably, the stirring temperature is 50°C, the stirring speed is 1000rpm, and the stirring time is 1h.
[0036] Furthermore, when preparing the first component, the stirring speed is 500-2000 rpm, the stirring time is 0.5-2h, and the standing time at room temperature is 8-15h; preferably, the stirring speed is 500-1500 rpm, the stirring time is 0.5-1.5h, and the standing time at room temperature is 8-12h; further preferably, the stirring speed is 1000 rpm, the stirring time is 1h, and the standing time at room temperature is 10h.
[0037] Furthermore, when preparing the second component, the stirring temperature is 50-70°C, the stirring rate is 2000-3500rpm, and the stirring time is 0.5-2h; preferably, the stirring temperature is 60-70°C, the stirring rate is 2000-3000rpm, and the stirring time is 0.5-1.5h; further preferably, the stirring temperature is 65°C, the stirring rate is 2500rpm, and the stirring time is 1h.
[0038] Furthermore, after mixing with the second component, the stirring time is 0.5-2 hours until the hydrogel matrix is formed; preferably, the stirring time is 0.5-1.5 hours; further preferably, the stirring time is 1 hour.
[0039] Furthermore, the reagent used to adjust the pH is a sodium hydroxide solution; preferably, the concentration of the sodium hydroxide solution is 0.1 mol / L.
[0040] Furthermore, the pH of the antibacterial composition is 6.5-7.5.
[0041] In a third aspect, the present invention provides use of any of the above-described antibacterial compositions in the preparation of products for treating or alleviating pet skin diseases.
[0042] Furthermore, the product may be one of medicine, pet food, and toiletries.
[0043] Furthermore, the medicine can be an oral medicine or an external medicine.
[0044] Furthermore, the external medicine can be one of a liquid preparation, an ointment, and a gel.
[0045] Furthermore, the toiletries may be bath shampoo or bath liquid.
[0046] Furthermore, the pathogenic bacteria of the pet skin disease is Staphylococcus pseudintermedius.
[0047] Compared with the prior art, the antibacterial composition and its preparation method and application described in the present invention have the following advantages:
[0048] The antibacterial composition of the present invention can significantly reduce the growth ability, adhesion ability and bactericidal ability of Staphylococcus pseudintermedius through the synergistic effect between the components, especially the green tea extract, the pomegranate peel extract and the grape seed extract. It not only provides a safe and effective solution for pet skin diseases, but also avoids the risk of pet owners contracting skin diseases. At the same time, it meets the market demand for healthy and natural pet skin disease care products and has good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0049] The accompanying drawings constituting a part of the present invention are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute an improper limitation of the present invention. In the accompanying drawings:
[0050] Figure 1 This is a schematic diagram of the results of the inhibition zone experiment;
[0051] Figure 2 Schematic diagram of bacterial growth curve results drawn for the antibacterial growth curve experiment;
[0052] Figure 3 This is a schematic diagram of the bacterial turbidity results of the antibacterial growth curve experiment;
[0053] Figure 4 This is a schematic diagram of the live bacteria counting experiment results;
[0054] Figure 5 Schematic diagram of the bacterial adhesion experiment results;
[0055] Figure 6 Schematic diagram of the scanning electron microscopy results of bacteria. DETAILED DESCRIPTION
[0056] It should be noted that, in the absence of conflict, the embodiments of the present invention and the features in the embodiments may be combined with each other.
[0057] The present invention will be described in detail below with reference to the accompanying drawings and in conjunction with embodiments.
[0058] Example 1
[0059] The antibacterial composition in this embodiment includes, by mass, 1 part of green tea extract, 0.5 part of pomegranate peel extract, 0.5 part of grape seed extract, 0.01 part of cinnamon extract, 0.1 part of peppermint oil, 1 part of rhamnose, 0.5 part of mannose, 1 part of gel polymer excipient, 10 parts of moisturizer, 1 part of aloe polysaccharide, 0.5 part of zinc hyaluronate, 0.3 part of zinc gluconate, 0.2 part of zinc citrate, 2 parts of PEG-40 castor oil, 1 part of triethanolamine, and 80.89 parts of water, wherein the green tea extract, pomegranate peel extract, and grape seed extract were all purchased from Shaanxi Yizhimin Plant Technology Co., Ltd.
[0060] The preparation method of the antibacterial composition in this embodiment comprises the following steps:
[0061] (1) Weigh 1 part of green tea extract, 0.5 parts of pomegranate peel extract, 0.5 parts of grape seed extract, and 0.01 parts of cinnamon extract in appropriate amounts of deionized water, stir magnetically at 45°C and 6500 rpm for 10 min until completely dissolved, cool to room temperature to obtain a plant extract antibacterial solution, and seal in a volumetric flask for later use;
[0062] (2) Weigh 1 part of aloe polysaccharide, 1 part of rhamnose, and 0.5 part of mannose by mass and add them to an appropriate amount of deionized water. Perform high-speed shear emulsification at a rate of 10,000 rpm for 10 min. After the emulsification is uniform, use high-pressure homogenization (pressure of 60 MPa) to obtain a polysaccharide antibacterial liquid. The liquid is then cooled to room temperature to obtain a polysaccharide antibacterial liquid, which is then packaged in a volumetric flask for later use.
[0063] (3) Weigh 0.5 parts of zinc hyaluronate by mass and add it to an appropriate amount of deionized water. Stir the mixture with a magnetic stirrer at 1000 rpm for 60 min at 50°C until it is completely dissolved. Cool the mixture to room temperature to obtain zinc hyaluronate skin care liquid. Seal the solution in a volumetric flask for later use.
[0064] (4) Weigh 1 part of a gel polymer excipient by mass. The gel polymer excipients used in this embodiment are carbomer 934 and hydroxypropyl methylcellulose (mass ratio is 1:1); add the gel polymer excipient to deionized water, stir magnetically at a rate of 1500 rpm for 1 hour, and then soak at room temperature for 10 hours to allow it to be fully hydrated and swollen, thereby obtaining a first component;
[0065] (5) Weigh 0.3 parts of zinc gluconate, 0.2 parts of zinc citrate, 2 parts of PEG-40 castor oil and 0.1 parts of peppermint oil by weight, add them into deionized water, stir them magnetically at 2500 rpm at 65 °C for 1 h to completely dissolve them, and obtain the second component;
[0066] (6) After adding 10 parts of moisturizing agent and 1 part of triethanolamine to the first component and grinding evenly, slowly add it to the second component and stir and mix continuously for 1 hour until the hydrogel matrix is formed. The moisturizing agents used in this embodiment are glycerol and sorbitol (mass ratio is 1:1). Then, plant extract antibacterial liquid, polysaccharide antibacterial liquid and hyaluronic acid zinc skin care liquid are added in sequence. After stirring and mixing, the pH is adjusted with 0.1 mol / L NaOH solution to obtain a natural antibacterial composition for pets. The pH of the natural antibacterial composition for pets prepared in this embodiment is 7.28. The product is brown and transparent, has good formability, no stratification, and is easy to spread.
[0067] Example 2
[0068] The difference from Example 1 is that 0.5 parts of green tea extract, 0.5 parts of pomegranate peel extract and 1 part of grape seed extract are added. The pH value of the natural antibacterial composition for pets prepared in this example is 7.05, the product is brown and transparent, has formability, no stratification, and is easy to spread.
[0069] Example 3
[0070] The difference from Example 1 is that 0.5 parts of green tea extract, 1 part of pomegranate peel extract and 0.5 parts of grape seed extract are added. The pH value of the natural antibacterial composition for pets prepared in this example is 7.35, the product is brown and transparent, has formability, no stratification, and is easy to spread.
[0071] Example 4
[0072] The difference from Example 1 is that 0.1 part of cinnamon extract, 1 part of peppermint oil, 0.5 part of rhamnose, 1 part of mannose, 0.51 part of gel polymer excipient, 5 parts of moisturizer, 2 parts of aloe polysaccharide, 1 part of zinc hyaluronate, 1 part of zinc gluconate, 0.5 part of zinc citrate, 3 parts of PEG-40 castor oil, and 2 parts of triethanolamine are added. The pH value of the natural antibacterial composition for pets prepared in this example is 6.97, the product is brown and transparent, has formability, no stratification, and is easy to spread.
[0073] Example 5
[0074] The difference from Example 1 is that 0.01 part of cinnamon extract, 0.1 part of peppermint oil, 0.5 part of rhamnose, 0.5 part of mannose, 0.5 part of gel polymer excipient, 14 parts of moisturizer, 0.1 part of aloe polysaccharide, 0.2 part of zinc hyaluronate, 0.1 part of zinc gluconate, 0.1 part of zinc citrate, 0.5 part of PEG-40 castor oil, and 1 part of triethanolamine are added. The pH value of the natural antibacterial composition for pets prepared in this example is 6.89, the product is brown and transparent, has formability, no stratification, and is easy to spread.
[0075] Comparative Example 1
[0076] The difference from Example 1 is that 1 part of green tea extract is additionally added to replace 0.5 parts of pomegranate peel extract and 0.5 parts of grape seed extract. The pH value of the natural antibacterial composition for pets prepared in this comparative example is 7.03, the product is brown and transparent, has formability, no stratification, and is easy to spread.
[0077] Comparative Example 2
[0078] The difference from Example 1 is that 1 part of pomegranate peel extract is additionally added to replace 0.5 parts of green tea extract and 0.5 parts of grape seed extract. The pH value of the natural antibacterial composition for pets prepared in this comparative example is 6.89, the product is yellow and transparent, has formability, no stratification, and is easy to spread.
[0079] Comparative Example 3
[0080] The difference from Example 1 is that 1 part of grape seed extract is additionally added to replace 0.5 parts of green tea extract and 0.5 parts of pomegranate peel extract. The pH value of the natural antibacterial composition for pets prepared in this comparative example is 7.12, and the product is dark brown and transparent, has formability, no stratification, and is easy to spread.
[0081] Comparative Example 4
[0082] Commercially available pet skin spray (the main active ingredients are silver peptide, Cistanche deserticola extract, Cordyceps militaris extract, Usnea barbata extract, Centella asiatica flower / leaf / stem extract, licorice root extract, and gentian extract).
[0083] Inhibition zone test
[0084] The punching method was used to determine the antibacterial activity of the products of Examples 1-5 and Comparative Examples 1-4 against Staphylococcus pseudointermedia. The Staphylococcus pseudointermedia used in this experiment was ATCC 49444, purchased from Shanghai Collection of Microorganisms. In a sterile operating table, the LB solid culture medium sterilized by high temperature and high pressure was cooled to 45-50°C, and a 1% suspension of Staphylococcus pseudointermedia (107 CFU / mL) was added. After mixing, the mixture was allowed to stand until the LB solid culture medium solidified. After the culture medium solidified, a hole puncher with a diameter of 10 mm was used to punch holes in the culture medium. 200 μL of each of the products of Examples 1-5 and Comparative Examples 1-4 were taken and added to the corresponding marked holes, respectively, and sterile water was used as a blank control. Finally, the culture dish with the antibacterial solution was placed in a 37°C constant temperature incubator for 24 h, and the antibacterial circle diameter was observed and recorded. The experiment was repeated three times independently, and the average value was taken as the measurement result. The results are shown in the table below. Figure 1 shown.
[0085] Depend on Figure 1The results of the inhibition zone diameter show that compared with comparative examples 1-4, the diameters of the inhibition zones of Examples 1-5 are significantly higher than those of the comparative examples, proving that the simultaneous addition of green tea extract, pomegranate peel extract and grape seed extract in Examples 1-5 can produce a synergistic effect compared with the addition of a single extract, and significantly improve the antibacterial ability against Staphylococcus pseudointermedia. Among them, the diameters of the inhibition zones of Examples 1 and 4 are significantly larger than those of Examples 2, 3 and 4, indicating that the present invention has a significant in vitro inhibitory effect on Staphylococcus pseudointermedia, among which Examples 1 and 4 have the most prominent antibacterial activity. Therefore, Examples 1 and 4 will be selected for subsequent comparison with the comparative example antibacterial experiments.
[0086] Antibacterial growth curve experiment
[0087] Staphylococcus pseudintermedius was cultured to the logarithmic growth phase, and the products of Examples 1, 4 and Comparative Examples 1-4 were mixed with a bacterial suspension (the concentration of Staphylococcus pseudintermedius was 1×10 7 CFU / mL) were mixed in different centrifuge tubes. Bacteria treated with PBS were used as blank controls. After incubation in a full-temperature shaking incubator at 37°C and 250rpm for 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 hours, 100ul of bacterial suspension was taken from each centrifuge tube and placed in a 96-well plate. The optical density (OD) value of the bacterial suspension at a wavelength of 600nm was measured using an ELISA reader, and a bacterial growth curve was drawn. Another 200uL of bacterial culture solution was taken in a 96-well plate to observe the degree of bacterial turbidity. The results are shown in the figure. Figure 2-3 shown.
[0088] Depend on Figure 2-3 It can be seen that the OD600 nm value of the bacterial solution of the pseudo-intermediate Staphylococcus in the blank control group rose to 2.37 and the bacterial solution was very turbid, while the OD600 nm values of Example 1 and Example 4 were 0.160 and 0.525, respectively, the bacterial solution was relatively clear, and the OD600 nm value was significantly lower than that of the blank control group, indicating that the antibacterial composition prepared by the present invention can significantly inhibit the growth ability of pseudo-intermediate Staphylococcus. The OD600 nm values of comparative examples 1-4 after culturing bacteria were 0.97, 1.26, 1.708 and 2.14, respectively, and the degree of decrease in the OD600 nm value was very limited compared with the control. It can be seen that the ability of the product of the present invention to inhibit pseudo-intermediate Staphylococcus is significantly better than that of the comparative example.
[0089] Live bacteria count test
[0090] 100ul of PBS samples of Examples 1, 4 and Comparative Examples 1-4 were mixed with 3ml of bacterial suspension (the concentration of Staphylococcus pseudintermedius was 1x10 7CFU / mL) were mixed in different sterile centrifuge tubes. Bacteria treated with PBS were used as blank controls. After culturing in a full-temperature shaking incubator at 37°C and 220 rpm for 24 hours, 0.1 mL of bacterial culture solution was spread on an LB solid culture dish to quantify the number of bacterial colonies in the dish. The colony count was performed when the number of colonies was between 30 CFU and 300 CFU. The total colony count (CFU / mL) was calculated as follows: the number of colonies × dilution factor × 10 (0.1 mL of dilution solution was spread on the plate). The experiment was repeated three times, and the experimental data was averaged. The results were expressed as log10 cfu / mL. The results are shown in the figure. Figure 4 shown.
[0091] Depend on Figure 4 It can be seen that the total number of live bacteria in the blank control group after culturing Staphylococcus pseudointermediates increased to 8.09, while the total number of live bacteria in Example 1 and Example 4 decreased to 0.49 and 1.47, respectively, which were significantly lower than those in the blank control group, indicating that the antibacterial composition prepared by the present invention can significantly reduce the number of live bacteria in Staphylococcus pseudointermediates. The total number of live bacteria in Comparative Examples 1-4 after culturing bacteria were 4.33, 5.53, 5.33 and 6.04, and the degree of decrease in the total number of live bacteria in the Log value was limited compared with the blank control group. It can be seen that the ability of the product of the present invention to inhibit Staphylococcus pseudointermediates is significantly better than that of the comparative example.
[0092] Bacterial adhesion assay
[0093] Staphylococcus pseudintermedius was cultured to the logarithmic growth phase, and the samples of Examples 1, 2 and Comparative Examples 1-4 were mixed with a bacterial suspension (the concentration of Staphylococcus pseudintermedius was 1×10 7 CFU / mL) and 1 mL of the mixture was added to a 24-well cell culture plate (each well contained a sterile glass slide). Bacteria treated with PBS were used as blank controls. After incubation in a constant temperature shaking incubator at 37°C and 220 rpm for 120 min, non-adherent bacterial cells were washed away with PBS, and the glass slide was transferred to a test tube containing 15 mL PBS. After ultrasonic treatment at 20 kHz and 25°C for 60 s, the bacterial adhesion rate was evaluated by the plate count method. The results are shown in the figure. Figure 5 shown.
[0094] Depend on Figure 5It can be seen that the bacterial adhesion rate of Staphylococcus pseudointermedia after culturing in the blank control group increased to 98.73%, while the bacterial adhesion rates of Example 1 and Example 4 were reduced to 16.41% and 21.53%, respectively, which were significantly lower than those of the blank control group, indicating that the antibacterial composition prepared by the present invention can significantly reduce the adhesion rate of Staphylococcus pseudointermedia. The bacterial adhesion rates of Comparative Examples 1-4 after culturing bacteria were 49.43%, 61.56%, 58.96% and 73.3%, respectively. It can be seen that the ability of the product of the present invention to inhibit the adhesion of Staphylococcus pseudointermedia is significantly better than that of the comparative example.
[0095] Bacteria scanning electron microscopy
[0096] Staphylococcus pseudintermedius was cultured to the logarithmic growth phase, and the products of Example 1 and Comparative Example 1 were mixed with a bacterial suspension (the concentration of Staphylococcus pseudintermedius was 1×10 7 CFU / mL) and an equal volume of PBS was used as a blank control. The cells were cultured in a constant temperature shaking incubator at 37°C and 220pm for 24 hours. Take 1mL of fresh culture solution, centrifuge at 4500r for 15 minutes, collect the cells, and immediately fix them in a 1.5ml (2mL) centrifuge tube containing 2.5% valeraldehyde, and place them in a 4-degree refrigerator for 12h-24h. Pour out the fixative, rinse the sample three times with 0.1M, pH7.0 phosphate buffer, 15min each time, fix the sample with 1% osmium acid solution for 1-2h, carefully remove the osmium acid waste solution, and rinse 3 times with 0.1M phosphate buffer, 15min each time. The samples were then dehydrated with ethanol solutions of gradient concentrations (including 30%, 50%, 70%, 80%, 90% and 95%), each concentration was treated for 15 minutes, and then treated with 100% ethanol for 20 minutes. Finally, ethanol: tert-butanol (2:1, 1:1) and 100% tert-butanol were replaced once. Finally, the bacterial tert-butanol suspension of appropriate concentration was dripped onto aluminum foil, precooled at -80°C, and placed in a freeze dryer for freeze drying. The dried samples were fixed on aluminum foil and sprayed with gold. The bacterial morphology was observed with a scanning electron microscope and photographed. The results are as follows: Figure 6 shown.
[0097] Depend on Figure 6 It can be seen from the results of scanning electron microscopy that the cells of the Staphylococcus aureus in the blank control group were intact in morphology, and the cells were round, plump and smooth; the Staphylococcus aureus treated with Comparative Examples 1 and 4 were inhibited and destroyed to a certain extent, and the number of bacteria decreased compared with the blank control group; the Staphylococcus aureus treated with Example 1 was severely damaged, with obvious collapse on the cell surface, changes in bacterial morphology, outflow of cell contents, obvious wrinkles and damage to the bacterial cell membrane, and a significant decrease in the number of bacteria, indicating that the product of the present invention is significantly better than the comparative example in its ability to destroy and inhibit the bacterial morphology of Staphylococcus aureus.
[0098] Experimental study on the therapeutic effect of bacterial skin diseases in pet dogs and cats
[0099] Experimental animals: A total of 16 dogs and cats suffering from bacterial skin diseases were selected and randomly divided into 2 groups, 8 experimental groups and 8 control groups.
[0100] Experimental method: Locally examine the cat's body surface for the degree of itching, the degree of skin damage, the number of rashes or pustules, and the location and distribution of skin lesions.
[0101] Dosage method: The experimental group evenly applied the antibacterial composition of Example 1 to the affected area of the pet once a day for 14 consecutive days; the control group did not use the antibacterial composition.
[0102] Microbiological examination: Samples were collected from the affected parts of the case animals, the pathogenic bacteria were isolated and Staphylococcus pseudintermedius was identified, and finally the bacteria were counted. The results are shown in Table 1.
[0103] Table 1 Microbiological detection test results
[0104]
[0105] As can be seen from Table 1, the natural antibacterial composition of the present invention has an inhibition rate of 99.917% on the pathogenic bacteria Staphylococcus pseudointermedius in the affected part of the skin of dogs with bacterial skin diseases, and an inhibition rate of 99.648% on Staphylococcus pseudointermedius in the affected part of cats with bacterial skin diseases. It can be seen that the product of the present invention can effectively improve pet bacterial skin diseases by inhibiting the number of Staphylococcus pseudointermedius in the affected part.
[0106] The treatment effects can be divided into three categories: cured, effective, and ineffective. Cured means that after taking the medicine, the inflammatory secretions of the affected skin area completely disappear, there is no odor in the affected area, and the symptoms such as rashes, dandruff, and pustules all disappear. Effective means that after taking the medicine, the inflammatory secretions of the affected skin area are significantly reduced, there is almost no odor in the affected area, and the symptoms such as rashes, dandruff, and pustules are alleviated. Ineffective means that after taking the medicine, the inflammatory secretions of the affected skin area still exist, the affected area still has an odor, and the symptoms such as rashes, dandruff, and pustules have not improved.
[0107] The recurrence rate was determined by examining the skin of dogs and cats for clinical symptoms within the first week after they were cured and medication was stopped to determine if there was any recurrence of the disease. The results are shown in Table 2.
[0108] Table 2 Results of clinical bacterial skin disease treatment experiments on pet dogs and cats
[0109]
[0110] As can be seen from Table 2, the natural antibacterial composition of the present invention has a cure rate of 75% for dogs with bacterial skin diseases and a cure rate of 100% for cats with bacterial skin diseases. The recurrence rate monitoring results were observed within 1 week after drug withdrawal. In the experimental treatment group, 3 dogs with bacterial skin diseases were cured and no recurrence was observed after the cure, and 4 cats with bacterial skin diseases were cured and no recurrence of bacterial skin diseases was observed. It can be seen that the product of the present invention can effectively improve bacterial skin diseases in pets, and the recurrence rate is low.
[0111] The embodiments described above are only some embodiments of the present invention, rather than all embodiments. Based on the embodiments of the present invention, other embodiments obtained by those skilled in the art without creative work shall all fall within the scope of protection of the present invention.
Claims
1. An antibacterial composition, characterized in that The antibacterial composition consists of 0.5-1 part of green tea extract, 0.5-1 part of pomegranate peel extract, 0.5-1 part of grape seed extract, 0.01-0.1 part of cinnamon extract, 0.1-1 part of peppermint oil, 0.5-1 part of rhamnose, 0.5 part of mannose, 0.5-1 part of gel polymer excipient, 5-14 parts of moisturizing agent, 0.1-2 parts of aloe polysaccharide, 0.2-1 part of zinc hyaluronate, 0.1-1 part of zinc gluconate, 0.1-0.5 part of zinc citrate, 0.5-3 parts of PEG-40 castor oil and 0.5-2 parts of triethanolamine in parts by mass.
2. The antibacterial composition according to claim 1, characterized in that: The gel polymer excipient includes at least one of carbomer 934 and hydroxypropyl methylcellulose.
3. The antibacterial composition according to claim 1, characterized in that: The humectant includes at least one of glycerin and sorbitol.
4. The method for preparing the antibacterial composition according to any one of claims 1 to 3, characterized in that: The preparation method comprises the following steps: Green tea extract, pomegranate peel extract, grape seed extract and water are stirred until completely dissolved to obtain a plant extract antibacterial liquid.
5. The preparation method according to claim 4, characterized in that: The preparation method comprises the following steps: Green tea extract, pomegranate peel extract, grape seed extract, and cinnamon extract are stirred with water until completely dissolved to obtain a plant extract antibacterial liquid; Mixing aloe polysaccharide, rhamnose, mannose and water to obtain polysaccharide antibacterial liquid; Mixing zinc hyaluronate with water to obtain zinc hyaluronate liquid; Fully hydrating and swelling the gel polymer excipient with water to obtain a first component; Mixing zinc gluconate, zinc citrate, castor oil, peppermint oil and water to obtain a second component; The first component, moisturizer and triethanolamine are evenly ground, the second component is added, and stirred until the hydrogel matrix is formed, and plant extract antibacterial liquid, polysaccharide antibacterial liquid and hyaluronic acid zinc liquid are added in sequence and stirred evenly to obtain an antibacterial composition.
6. Use of the antibacterial composition according to any one of claims 1 to 3 in the preparation of a product for treating or alleviating pet skin diseases, wherein the pathogenic bacteria of the pet skin diseases is Staphylococcus pseudintermedius, and the product is a medicine or a toiletries.
Citation Information
Patent Citations
Antibacterial composition, compound marbofloxacin spray of antibacterial composition and preparation method of compound marbofloxacin spray
CN112245438A
Compositions for treating topical skin bacterial conditions
CN117715651A
Plant medicinal composition with air pollution resistance effect and application of plant medicinal composition
CN105748347A
